Corporate director convicted of insider trading

According to court filings, in May 2023, Haghighat learned about the proposed acquisition of the Seattle-based biopharmaceutical company, Chinook Therapeutics, Inc., where has was a director, by Novartis AG, in a US$3.2-billion deal.In anticipation of that deal, he then bought securities in the company, and tipped three others, who also bought shares. And, in June 2023, the two companies negotiated a deal that caused the target company’s shares to spike, generating profits for the four traders.Now, the jury ...